Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weaning From Nasal High Flow Therapy: an Explorative Study Assessing the Usefulness of the ROX Index to Predict Outcome of the Weaning Process in Combination With a Withdrawal Trial

NCT05210881 is registered in ClinicalTrials.gov with Hôpital Louis Mourier as lead sponsor.

NCT NCT05210881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05210881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weaning From Nasal High Flow Therapy: an Explorative Study Assessing the Usefulness of the ROX Index to Predict Outcome of the Weaning Process in Combination With a Withdrawal Trial
Lead sponsor
Hôpital Louis Mourier
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
August 31, 2021
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypoxemic respiratory failure, acute respiratory distress syndrome, respiratory distress syndrome, adult, weaning failure